Design and Development of Integrase Inhibitors as Anti-HIV Agents

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|10|18|1779-1794

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.10, Iss.18, 2003-09, pp. : 1779-1794

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Inhibitors of HIV Integrase: The Discovery of Potential Anti-HIV Therapeutic Agents

By  

Current Pharmaceutical Design, Vol. 9, Iss. 31, 2003-12 ,pp. : 2553-2565

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies in the Design of Prodrugs of Anti-HIV Agents

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 13, 2003-09 ,pp. : 1467-1495

Bentham Science Publishers

Access to resources Recommend Favorite

Design of Second Generation HIV-1 Integrase Inhibitors

By  

Current Pharmaceutical Design, Vol. 13, Iss. 2, 2007-01 ,pp. : 129-141

Bentham Science Publishers

Access to resources Recommend Favorite

Developing G-quartet oligonucleotides as novel anti-HIV agents: focus on anti-HIV drug design

By Jing N.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 8, 2000-08 ,pp. : 1777-1785

Informa Healthcare

Access to resources Recommend Favorite

Recent Development of New Substituted Indole and Azaindole Derivatives as Anti-HIV Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 12, 2013-01 ,pp. : 1700-1708

Bentham Science Publishers

Access to resources Recommend Favorite